ArabFinance: Memphis Pharmaceutical (MPCI) announced, in a statement sent to EGX, the Board of Directors (BoD) held on Feb. 17.
The company's BoD approved financial results for the financial period ending Jan. 31, 2019, which revealed posting tax-deducted profits of EGP 3.53 million, compared to incurring losses of EGP 17.1 million a year earlier, with121% increase.
The company attributed the profit rise to the increase in production and sales.
Copyright © 2020 Arab Finance Brokerage Company All rights reserved. Provided by SyndiGate Media Inc. (Syndigate.info).
Disclaimer: The content of this article is syndicated or provided to this website from an external third party provider. We are not responsible for, and do not control, such external websites, entities, applications or media publishers. The body of the text is provided on an “as is” and “as available” basis and has not been edited in any way. Neither we nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this article. Read our full disclaimer policy here.
